Sunbird Bio

New Data Demonstrate Sunbird Bio’s APEX Diagnostic Test Accurately Differentiates Key Alzheimer’s Disease Biomarker in Blood

Blood-based diagnostic effectively discriminated between patients who were positive versus negative for amyloid beta on PET scans Data will be shared in a poster presentation at AD/PD 2024 on 8-9 March. 5 March 2024 -- Massachusetts, US and Singapore -- Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment...
35 Cambridgepark Drive Suite 100 Cambridge, MA 02140

+1 857-242-0034